EMMA - Emmaus Life Sciences GAAP EPS of -$0.18 revenue of $4.3M misses by $1.7M August, 15 2022 05:15 PM Emmaus Life Sciences Incorporation Emmaus Life Sciences press release ( OTCQX:EMMA ): Q2 GAAP EPS of -$0.18. Revenue of $4.3M misses by $1.7M . At June 30, 2022, the company had cash and cash equivalents of $1.0 million For further details see: Emmaus Life Sciences GAAP EPS of -$0.18, revenue of $4.3M misses by $1.7M